Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology Inc. (NASDAQ: ALGN) is a prominent global medical device company known for designing and manufacturing the Invisalign® System, the world’s most advanced clear aligner system, iTero™ intraoral scanners, and exocad™ CAD/CAM software. These innovations enable digital orthodontics and restorative dentistry, improving patient outcomes and practice efficiencies for over 261,000 doctor customers worldwide. Since its establishment, Align Technology has treated over 17.6 million patients with Invisalign, driving the evolution of digital dentistry through the Align Digital Platform™.
The company’s flagship product, the Invisalign System, has revolutionized the approach to orthodontic treatment. Utilized in over 90 countries, Invisalign combines proprietary virtual modeling software and rapid mass-manufacturing processes to develop customized aligners for each patient. It's a preferred choice for treating a wide range of malocclusions, from simple to complex cases. The system has gained the trust of over 230,000 Invisalign-trained dentists and orthodontists globally.
Align Technology also offers the iTero intraoral scanner, which uses advanced parallel confocal imaging technology to capture detailed digital impressions of patients' teeth, facilitating accurate treatment plans and enhancing patient communication. Over 85% of Invisalign cases start with digital scans, underscoring the importance of iTero technology in modern dental practices.
In 2024, the company launched the iTero Lumina™, a next-generation intraoral scanner that offers a 3X wider field of capture with a significantly smaller and lighter wand, providing faster, more accurate scans and superior patient comfort. This innovation exemplifies Align's commitment to continuous improvement and leveraging emerging technologies.
Align’s commitment to innovation is further demonstrated by its recent acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions. This acquisition strengthens Align’s strategic innovation roadmap and enhances its manufacturing capabilities for 3D printed products such as the Invisalign Palatal Expander System. This new system offers a removable, clinically effective alternative to traditional palatal expanders, further solidifying Align’s position at the forefront of digital orthodontics.
The company’s financial health remains robust, with significant investments in R&D aimed at driving future growth. Align continues to support clinical and scientific research worldwide through its annual Research Awards Program, fostering advancements in dental care.
Align Technology maintains a strong market presence, bolstered by strategic partnerships and a broad product portfolio, ensuring its role as a leader in the rapidly evolving dental industry. For more information, visit www.aligntech.com.
Align Technology, a leader in clear aligner systems, announced its third-quarter 2022 financial results will be released on October 26, 2022, at 4:00 p.m. ET. A conference call to discuss these results will follow at 4:30 p.m. ET. The call can be accessed via dial-in or streamed online. Align has served over 13.4 million patients with its innovative products and continues to grow in the digital orthodontics space. Investors can find financial results and listen to the conference call on their Investor Relations website.
Align Technology has launched Invisalign Virtual Care AI, enhancing remote monitoring with AI-assisted features for orthodontists. This innovation allows doctors to manage patient treatment via the Invisalign Doctor Site without separate portals, streamlining workflows. Key functionalities include AI-assisted Automatic Assessment for tracking aligner fit and Automated Notifications to advise patients on their treatment progress. The system integrates with the Align Digital Platform, improving patient compliance and treatment tracking efficiency.
Align Technology has opened its first Europe, Middle East & Africa (EMEA) manufacturing facility in Wroclaw, Poland, marking a significant investment in the region. The new facility will support Align's EMEA operations and aims to produce almost 1 million clear aligner parts daily. This initiative is expected to create over 2,500 jobs by 2025. The facility aligns with Align's strategy to enhance service quality and delivery times for its customers, as the EMEA region contains over 7 million annual orthodontic cases and 150 million potential consumers.
Align Technology (NASDAQ: ALGN) reported Q2'22 revenues of $969.6 million, down 0.4% sequentially and 4.1% year-over-year. Clear Aligner sales decreased to $798.4 million, while Imaging Systems revenues rose 4.7% sequentially. The operating income was $188.2 million with a margin of 19.4%. Net income was $112.8 million, translating to $1.44 per diluted share. The company faced significant foreign exchange impacts, totaling approximately $15.3 million sequentially. Align purchased 757,000 shares at an average price of $264.37, demonstrating shareholder return strategy amidst economic challenges.
Align Technology, Inc. (NASDAQ: ALGN) will report its second quarter 2022 financial results on July 27, 2022, after market close at 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET to discuss the results, accessible via audio webcast. The archived version will be available for one month. Align Technology specializes in the design, manufacture, and sales of clear aligners, intraoral scanners, and CAD/CAM software, providing solutions to enhance efficiency and patient outcomes in orthodontics.
BetterInvesting Magazine has highlighted Align Technology (ALGN) as its 'Stock to Study' and Qualcomm Inc. (QCOM) as its 'Undervalued Stock' in the September 2022 issue. This selection, made by the Editorial Advisory and Securities Review Committee, aims to provide investors with educational insights amid recent market conditions. Ken Zendel, CEO of NAIC, notes that the current market pullback offers opportunities for investors to acquire growth stocks at reasonable prices. The magazine encourages individuals to utilize BetterInvesting's tools for informed investment decisions.
Align Technology (Nasdaq: ALGN) has awarded $275,000 in research grants through its twelfth Annual Research Award Program, funding eleven projects at universities worldwide. The initiative aims to further research capabilities in digital orthodontics and clear aligner treatment. Recipients include institutions from the Americas, Europe, and Asia Pacific, focusing on various topics such as distalization and pre-surgical treatment for cleft palates. Align emphasizes the growing interest in advancing dental technologies through these grants.
Align Technology, Inc. (NASDAQ: ALGN) will present at the Stifel 2022 Jaws & Paws Conference on June 1, 2022, from 8:00 to 8:30 AM ET in New York, NY. The presentation will be webcast live on Align's Investor Relations website, with an archived replay available for approximately three months. This event will feature CEO Joe Hogan, CFO John Morici, and Corporate Communications Director Madelyn Valente. Align is known for its Invisalign system, iTero scanners, and exocad software, revolutionizing digital orthodontics and restorative dentistry for over 217,000 doctors and 12.8 million patients globally.
Align Technology announces a partnership with Asana to launch Asana Smiles™, a workflow solution tailored for Invisalign-trained doctors in the U.S. This platform allows dental practices to efficiently manage patients' treatment journeys, from consultations to aligner delivery. The solution is designed to integrate seamlessly with existing systems, enhancing practice efficiency and patient care. It will be showcased at the American Association of Orthodontists' Annual Session from May 21-24, 2022, and is set for release next month, with future expansion plans.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
What is Align Technology's main product?
How many patients have been treated with Invisalign?
What technologies does Align Technology offer?
What is the iTero Lumina™ scanner?
What was the purpose of acquiring Cubicure GmbH?
How does Align Technology support scientific research?
What is the Align Digital Platform?
How many Invisalign-trained doctors are there globally?
What is the financial outlook for Align Technology?
Where can I find more information about Align Technology’s products?
